Anderson H - Search Results

1

A randomized study comparing chemotherapy alone with chemotherapy followed by radiotherapy in patients with pathologically staged IIIA Hodgkin's disease.

Crowther D, Wagstaff J, Deakin D, Todd I, Wilkinson P, Anderson H, Blackledge G, Jones M, Scarffe JH. Crowther D, et al. Among authors: anderson h. J Clin Oncol. 1984 Aug;2(8):892-7. doi: 10.1200/JCO.1984.2.8.892. J Clin Oncol. 1984. PMID: 6379122 Clinical Trial.

2

A randomised study of adjuvant MVPP chemotherapy after mantle radiotherapy in pathologically staged IA-IIB Hodgkin's disease: 10-year follow-up.

Anderson H, Crowther D, Deakin DP, Ryder WD, Radford JA. Anderson H, et al. Ann Oncol. 1991 Feb;2 Suppl 2:49-54. doi: 10.1007/978-1-4899-7305-4_8. Ann Oncol. 1991. PMID: 2049321 Free article. Clinical Trial.

3

A randomised study of adjuvant chemotherapy after mantle radiotherapy in supradiaphragmatic Hodgkin's disease PS IA-IIB: a report from the Manchester lymphoma group.

Anderson H, Deakin DP, Wagstaff J, Jones JM, Todd ID, Wilkinson PM, James RD, Steward WP, Blackledge G, Scarffe JH, et al. Anderson H, et al. Br J Cancer. 1984 Jun;49(6):695-702. doi: 10.1038/bjc.1984.110. Br J Cancer. 1984. PMID: 6375711 Free PMC article. Clinical Trial.

4

The prognostic significance of mediastinal bulk in patients with stage IA-IVB Hodgkin's disease: a report from the Manchester Lymphoma Group.

Anderson H, Jenkins JP, Brigg DJ, Deakin DP, Palmer MK, Todd ID, Crowther D. Anderson H, et al. Clin Radiol. 1985 Sep;36(5):449-54. doi: 10.1016/s0009-9260(85)80183-5. Clin Radiol. 1985. PMID: 4075707

5

Serum beta 2-microglobulin in patients with non-Hodgkin's lymphoma.

Anderson H, Scarffe JH, Swindell R, Crowther D. Anderson H, et al. Eur J Cancer Clin Oncol. 1983 Mar;19(3):327-31. doi: 10.1016/0277-5379(83)90129-3. Eur J Cancer Clin Oncol. 1983. PMID: 6190656

6

Prognostic significance of pretreatment serum beta 2-microglobulin levels in multiple myeloma.

Scarffe JH, Anderson H, Palmer MK, Crowther D. Scarffe JH, et al. Among authors: anderson h. Eur J Cancer Clin Oncol. 1983 Oct;19(10):1361-4. doi: 10.1016/0277-5379(93)90004-o. Eur J Cancer Clin Oncol. 1983. PMID: 6357802

7

A multivariate analysis of factors affecting survival in patients with high-grade histology non-Hodgkin's lymphoma.

Steward WP, Todd ID, Harris M, Jones JM, Blackledge G, Wagstaff J, Anderson H, Wilkinson PM, Crowther D. Steward WP, et al. Among authors: anderson h. Eur J Cancer Clin Oncol. 1984 Jul;20(7):881-9. doi: 10.1016/0277-5379(84)90159-7. Eur J Cancer Clin Oncol. 1984. PMID: 6547675

8

VAC (vincristine, adriamycin, cyclophosphamide) chemotherapy for metastatic carcinoma from an unknown primary site.

Anderson H, Thatcher N, Rankin E, Wagstaff J, Scarffe JH, Crowther D. Anderson H, et al. Eur J Cancer Clin Oncol. 1983 Jan;19(1):49-52. doi: 10.1016/0277-5379(83)90397-8. Eur J Cancer Clin Oncol. 1983. PMID: 6687868

9

Comparative toxicity of cisplatin, carboplatin (CBDCA) and iproplatin (CHIP) in combination with cyclophosphamide in patients with advanced epithelial ovarian cancer.

Anderson H, Wagstaff J, Crowther D, Swindell R, Lind MJ, McGregor J, Timms MS, Brown D, Palmer P. Anderson H, et al. Eur J Cancer Clin Oncol. 1988 Sep;24(9):1471-9. doi: 10.1016/0277-5379(88)90338-0. Eur J Cancer Clin Oncol. 1988. PMID: 3053207 Clinical Trial.

10

VAD chemotherapy--toxicity and efficacy--in patients with multiple myeloma and other lymphoid malignancies.

Anderson H, Scarffe JH, Lambert M, Smith DB, Chan CC, Chadwick G, McMahon A, Chang J, Crowther D, Swindell R. Anderson H, et al. Hematol Oncol. 1987 Jul-Sep;5(3):213-22. doi: 10.1002/hon.2900050308. Hematol Oncol. 1987. PMID: 3115884

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,117 results

Search Page

Filters